The Role of Aha1 in Cancer and Neurodegeneration

Overview

Journal Front Mol Neurosci

Date 2025 Jan 8

PMID 39776493

Authors

Brian S J Blagg

Kevin C Catalfano

Affiliations

Soon will be listed here.

Abstract

The 90 kDa Heat shock protein (Hsp90) is a family of ubiquitously expressed molecular chaperones responsible for the stabilization and maturation of >400 client proteins. Hsp90 exhibits dramatic conformational changes to accomplish this, which are regulated by partner proteins termed co-chaperones. One of these co-chaperones is called the activator or Hsp90 ATPase activity homolog 1 (Aha1) and is the most potent accelerator of Hsp90 ATPase activity. In conditions where Aha1 levels are dysregulated including cystic fibrosis, cancer and neurodegeneration, Hsp90 mediated client maturation is disrupted. Accumulating evidence has demonstrated that many disease states exhibit large hetero-protein complexes with Hsp90 as the center. Many of these include Aha1, where increased Aha1 levels drive disease states forward. One strategy to block these effects is to design small molecule disruptors of the Hsp90/Aha1 complex. Studies have demonstrated that current Hsp90/Aha1 small molecule disruptors are effective in both models for cancer and neurodegeration.

References

Tang J, Hu H, Zhou C, Zhang N . Human Aha1's N-terminal extension confers it holdase activity in vitro. Protein Sci. 2023; 32(9):e4735. PMC: 10443363. DOI: 10.1002/pro.4735. View

Amatya E, Blagg B . Recent advances toward the development of Hsp90 C-terminal inhibitors. Bioorg Med Chem Lett. 2022; 80:129111. PMC: 9869726. DOI: 10.1016/j.bmcl.2022.129111. View

Eichner R, Heider M, Fernandez-Saiz V, van Bebber F, Garz A, Lemeer S . Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016; 22(7):735-43. DOI: 10.1038/nm.4128. View

Woodford M, Sager R, Marris E, Dunn D, Blanden A, Murphy R . Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients. EMBO J. 2017; 36(24):3650-3665. PMC: 5730846. DOI: 10.15252/embj.201796700. View

Cao R, Shao J, Hu Y, Wang L, Li Z, Sun G . microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1. Cancer Cell Int. 2018; 18:49. PMC: 5879792. DOI: 10.1186/s12935-018-0551-x. View

Ihrig V, Obermann W . Identifying Inhibitors of the Hsp90-Aha1 Protein Complex, a Potential Target to Drug Cystic Fibrosis, by Alpha Technology. SLAS Discov. 2017; 22(7):923-928. DOI: 10.1177/2472555216688312. View

Wu K, Lin K, Li X, Yuan X, Xu P, Ni P . Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment. Front Immunol. 2020; 11:1731. PMC: 7417513. DOI: 10.3389/fimmu.2020.01731. View

McDowell C, Sutton R, Obermann W . Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue. Int J Biol Macromol. 2009; 45(3):310-4. DOI: 10.1016/j.ijbiomac.2009.06.012. View

Lotz G, Lin H, Harst A, Obermann W . Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone. J Biol Chem. 2003; 278(19):17228-35. DOI: 10.1074/jbc.M212761200. View

10.

Tripathi V, Darnauer S, Hartwig N, Obermann W . Aha1 can act as an autonomous chaperone to prevent aggregation of stressed proteins. J Biol Chem. 2014; 289(52):36220-8. PMC: 4276884. DOI: 10.1074/jbc.M114.590141. View

11.

Rani K, Gotmare A, Maier A, Menghal R, Akhtar N, Fangaria N . Identification of a chaperone-code responsible for Rad51-mediated genome repair. J Biol Chem. 2024; 300(6):107342. PMC: 11154708. DOI: 10.1016/j.jbc.2024.107342. View

12.

Mondol T, Silbermann L, Schimpf J, Vollmar L, Hermann B, Tych K . Aha1 regulates Hsp90's conformation and function in a stoichiometry-dependent way. Biophys J. 2023; 122(17):3458-3468. PMC: 10502475. DOI: 10.1016/j.bpj.2023.07.020. View

13.

Fangaria N, Rani K, Singh P, Dey S, Kumar K, Bhattacharyya S . DNA damage-induced nuclear import of HSP90α is promoted by Aha1. Mol Biol Cell. 2022; 33(14):ar140. PMC: 9727810. DOI: 10.1091/mbc.E21-11-0554. View

14.

Shiau A, Harris S, Southworth D, Agard D . Structural Analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell. 2006; 127(2):329-40. DOI: 10.1016/j.cell.2006.09.027. View

15.

Mangangcha I, Malik M, Kucuk O, Ali S, Brojen Singh R . Identification of key regulators in prostate cancer from gene expression datasets of patients. Sci Rep. 2019; 9(1):16420. PMC: 6848149. DOI: 10.1038/s41598-019-52896-x. View

16.

Inda M, Joshi S, Wang T, Bolaender A, Gandu S, Koren Iii J . The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction. Nat Commun. 2020; 11(1):319. PMC: 6965647. DOI: 10.1038/s41467-019-14082-5. View

17.

Han S, Ahn J, Lee S, Noh Y, Jung H, Lee M . Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers. Sci Rep. 2020; 10(1):7170. PMC: 7189385. DOI: 10.1038/s41598-020-63806-x. View

18.

Choudhary I, Lee H, Pyo M, Heo Y, Chae J, Yum S . Proteomic Investigation to Identify Anticancer Targets of Jellyfish Venom in Human Hepatocarcinoma HepG2 Cells. Toxins (Basel). 2018; 10(5). PMC: 5983250. DOI: 10.3390/toxins10050194. View

19.

Gao Y, Li Y, Liu Z, Dong Y, Yang S, Wu B . AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. J Hepatocell Carcinoma. 2023; 10:2021-2036. PMC: 10640837. DOI: 10.2147/JHC.S407680. View

20.

Liu X, Wang Y . Aha1 Is an Autonomous Chaperone for SULT1A1. Chem Res Toxicol. 2022; 35(8):1418-1424. PMC: 9378526. DOI: 10.1021/acs.chemrestox.2c00167. View